ArticlePharmaceutical research2025
DeepSeek-LLM with Adaptive RAG for Pharmaceutical Dissolution Prediction.
Article in Pharmaceutical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
purposeThis work aims to accelerate and enhance pharmaceutical drug dissolution prediction by integrating advanced Large Language Models (LLMs) and AI-diffusion models to reduce reliance on time-consuming, costly empirical experiments. The framework sets a foundation for broader adoption of generative AI in drug development.
methodsThis work introduces a DeepSeek based LLM framework augmented by prompt engineering (zero-shot, few-shot, chain-of-thought) and adaptive weighted retrieval-augmented generation (RAG) to systematize dissolution profile from basic physical properties. Moreover, a diffusion model synthesizes SEM-derived morphological parameters (e.g., particle size, surface area), circumventing error accumulation from multi-instrument characterization workflows. These parameters feed the RAG database, enabling LLM predictions grounded in structure-performance relationships rather than idealized assumptions.
resultsOverall, the LLM generated dissolution profile (few-shot chain-of-thought with RAG) provides a good agreement between experimental and the prediction result among others. Sensitivity analysis is investigated to quantify the reliability and stability of the prompt content. Additionally, diffusion-generated structural data from SEM images combined with the LLM's predictive capabilities are tested to connect macro-scale physical properties with microstructural characteristics, achieving a close profile trend with acceptable RMSE and PCC.
conclusionsThis study demonstrates the potential of the DeepSeek-based LLM framework to describe the dissolution of drug powders. Among the different system prompt strategies, few-shot chain-of-thought with RAG performs the best dissolution profile among others. While it may overcomplicate straightforward tasks in certain scenarios. The combination of diffusion models successfully bridges AI-driven insights (e.g., dissolution predictions) with physical and structural drug properties (e.g., particle geometry from SEM images).
Indexed as
Identifiers
41062798What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.